MILLENNIUM MANAGEMENT LLC Adds to Vanda Pharmaceuticals Inc (VNDA) Position -- Shares Look 25% Undervalued on GF Value

gurufocus.com · 2026-10-15

A Strategic Add in a Challenged Biotechnology Name On Sept. 30, 2026, MILLENNIUM MANAGEMENT LLC (Trades, Portfolio) executed an add transaction involving Vanda

TickrTrends take: Millennium Management's recent accumulation of VNDA shares aligns with the current TickrTrends assessment that the stock trades below its intrinsic value in the Healthcare sector. The reported 25% undervaluation gap suggests there may be room for price appreciation if market conditions shift or company fundamentals strengthen, though investors should monitor whether the company's pipeline progress and revenue trends support sustained valuation gains. A valuation-focused reader should track quarterly earnings reports and any updates on Vanda's drug development progress to determine if the current discount persists or narrows over time.

Read the full story at gurufocus.com →